CHLAMYDIAL PELVIC INFLAMMATORY DISEASE

This adverse event was reported 17 times

CHLAMYDIAL PELVIC INFLAMMATORY DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 13 0.0000
1 Nitroimidazole Antimicrobial [EPC] 1 0.0000
2 Arteriolar Vasodilator [EPC] 1 0.0000
3 Estrogen [EPC] 1 0.0000
4 Alkylating Drug [EPC] 1 0.0000
5 Vitamin D [EPC] 1 0.0000
6 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
7 Vitamin B12 [EPC] 1 0.0000
8 Vitamin C [EPC] 1 0.0000
9 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with CHLAMYDIAL PELVIC INFLAMMATORY DISEASE